Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:49 PM
Study NCT ID:
NCT04556669
Status:
UNKNOWN
Last Update Posted:
2021-05-27
First Post:
2020-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Senl_C22P CAR-T/CAR-TIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None